You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Squamous Cell Carcinoma of Head and Neck

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

Not yet recruiting
  • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Oct 24, 2023

Head and Neck Squamous-cell Carcinoma

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
    • (no location specified)
    Nov 5, 2023

    Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +3 more
    • Guangzhou, Guangdong, China
    • +4 more
    Nov 16, 2023

    Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
      • Hangzhou, Zhejiang, China
        Second Affiliated Hospital, School of Medicine, Zhejiang Univers
      Aug 22, 2023

      Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Carrilizumab, bevacizumab,capecitabine
      • (no location specified)
      Jul 20, 2023

      Needs and Preferences of Patients With Head-neck Cutaneous SCC

      Active, not recruiting
      • Cutaneous Squamous Cell Carcinoma
      • +10 more
      • Regular care with additional administration of a semi-structured interview
      • Maastricht, Netherlands
        Maastricht University Medical Center+
      Sep 13, 2023

      Head and Neck Squamous Cell Carcinoma Trial (HS-20093)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Aug 17, 2023

      Head and Neck Squamous Cell Carcinoma, Locally Advanced Operable Trial in Guangzhou (Cadonilimab, Docetaxel, Cisplatin)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Locally Advanced Operable
      • Guangzhou, Guangdong, China
      • +1 more
      Sep 4, 2023

      Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Nab paclitaxel
      • +2 more
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital
      Aug 24, 2023

      Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Chengdu (Netopitam Palonosetron capsules and dexamethasone)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma (HNSCC)
      • Netopitam Palonosetron capsules and dexamethasone
      • Chengdu, Sichuan, China
        Sichuan Cancer Hospital and Research Institute
      Oct 22, 2023

      Head and Neck Squamous Cell Carcinoma Trial (Zanzalintinib, Zanzalintinib-matched Placebo, Pembrolizumab)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Oct 9, 2023

      Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,

      Not yet recruiting
      • Metastatic Head-and-neck Squamous-cell Carcinoma
      • Recurrent Head and Neck Squamous Cell Carcinoma
      • Ficlatuzumab
      • +2 more
      • (no location specified)
      Sep 26, 2023

      Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Penpulimab injection
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University
      Oct 7, 2023

      Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Trial (Tislelizumab, BGB-A425, LBL-007)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Head and Neck Cancer
      • (no location specified)
      Jun 9, 2023

      Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Oct 25, 2023

      Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx

      Not yet recruiting
      • Squamous Cell Carcinoma of the Oral Cavity
      • +3 more
      • Eliminating RT to the elective neck
      • RT standard of care
      • Erlangen, Bavaria, Germany
        Universitätsklinikum Erlangen, Strahlenklinik
      Sep 8, 2023

      Squamous Cell Carcinoma of Head and Neck Trial in Toronto (fMRI, Oral Pimonidazole)

      Not yet recruiting
      • Squamous Cell Carcinoma of Head and Neck
      • fMRI
      • Oral Pimonidazole
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Center
      Oct 9, 2023

      Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)

      Not yet recruiting
      • Head Neck
      • Squamous Cell Carcinoma of Head and Neck
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 14, 2023

      Locally Advanced Head and Neck Squamous Cell Carcinoma Trial (Toripalimab)

      Not yet recruiting
      • Locally Advanced Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Mar 20, 2023

      Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

      Not yet recruiting
      • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
      • Black Raspberry
      • (no location specified)
      Oct 16, 2023

      Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

      Not yet recruiting
      • Recurrent Head and Neck Cancer
      • +5 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jul 30, 2023

      Prognostic Immune Biomarkers in HNSCC

      Completed
      • Head and Neck Cancer
      • Squamous Cell Carcinoma
      • Tumour immunoprofile evaluation
      • Ostrava, Moravian-Silesian Region, Czechia
        University Hospital Ostrava
      Jul 3, 2023

      Head and Neck Squamous Cell Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 17, 2023

      Head and Neck Squamous Cell Carcinoma, PET/CT Trial (Neck dissection)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • PET/CT
      • Neck dissection
      • (no location specified)
      Jan 31, 2023